A radiosensitizer is an agent that makes tumor cells more sensitive to radiation therapy. It is sometimes also known as a radiation sensitizer or radio-enhancer. Discover the latest research on radiosensitizers here.

January 19, 2021
Open Access

Quantifying nanotherapeutics penetration using hydrogel based microsystem as a new 3D in-vitro platform

BioRxiv : the Preprint Server for Biology
S. GoodarziCharlotte Riviere
December 22, 2020

Efficacy and toxicity of FLASH radiotherapy: A systematic review

Journal of Cancer Research and Therapeutics
Gilnaz OmyanSomayeh Gholami
January 15, 2021

Characterization of novel polydiacetylene gel dosimeter for radiotherapy

Biomedical Physics & Engineering Express
Y Peleg WalgI Orion
January 15, 2021
Open Access

Feasibility of using a novel automatic cardiac segmentation algorithm in the clinical routine of lung cancer patients

PloS One
Robert Neil FinneganDavide Fontanarosa
January 21, 2021
Open Access

Au-Pt Nanoparticle Formulation as a Radiosensitizer for Radiotherapy with Dual Effects.

International Journal of Nanomedicine
Song YangJunxing Huang
December 29, 2020

Brachytherapy for lung cancer

Bin QiuJunjie Wang
January 17, 2021
Open Access

Radiosensitization by Kinase Inhibition Revealed by Phosphoproteomic Analysis of Pancreatic Cancer Cells

Molecular & Cellular Proteomics : MCP
Svenja WiechmannSophie Dobiasch
December 23, 2020
Open Access

Fancy-Shaped Gold-Platinum Nanocauliflowers for Improved Proton Irradiation Effect on Colon Cancer Cells

International Journal of Molecular Sciences
Bartosz KlebowskiMagdalena Parlinska-Wojtan
December 30, 2020

Mithramycin A radiosensitizes EWS:Fli1+ Ewing sarcoma cells by inhibiting double strand break repair

International Journal of Radiation Oncology, Biology, Physics
Mei Yun LinJason A Horton
January 21, 2021
Open Access

Effect of Gold Nanoparticle Radiosensitization on Plasmid DNA Damage Induced by High-Dose-Rate Brachytherapy.

International Journal of Nanomedicine
Katsunori YogoHiroshi Yasuda
January 13, 2021

In vitro effects of Trastuzumab Emtansine (T-DM1) and concurrent irradiation on HER2-positive breast cancer cells

Cancer radiothérapie : journal de la Société française de radiothérapie oncologique
Fabien MignotFrédérique Megnin-Chanet
December 29, 2020

5-Aminolevulinic acid radiodynamic therapy for treatment of high-grade gliomas: A systematic review.

Clinical Neurology and Neurosurgery
Nathan J Nordmann, Alex P Michael
January 13, 2021
Open Access

Individual dosimetry system for targeted alpha therapy based on PHITS coupled with microdosimetric kinetic model.

EJNMMI Physics
Tatsuhiko SatoTadashi Watabe
January 16, 2021

Synergic effects of nanoparticles-mediated hyperthermia in radiotherapy/chemotherapy of cancer.

Life Sciences
Keywan MortezaeeMasoud Najafi

Sign up to follow this feed and discover related papers.

Related Feeds

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.

Biosensors for Cancer Detection

Biosensors are devices that are designed to detect a specific biological analyte by essentially converting a biological entity (ie, protein, DNA, RNA) into an electrical signal that can be detected and analyzed. The use of biosensors in cancer detection and monitoring holds vast potential. Biosensors can be designed to detect emerging cancer biomarkers and to determine drug effectiveness at various target sites. Biosensor technology has the potential to provide fast and accurate detection, reliable imaging of cancer cells, and monitoring of angiogenesis and cancer metastasis, and the ability to determine the effectiveness of anticancer chemotherapy agents.

Breast Cancer: Chemo-Resistance

Some cancers are difficult to treat and aggressive including the "triple-negative" breast cancer. This type of cancer is chemoresistant even before chemotherapy begins. Here are the latest discoveries chemo-resistance in breast cancer.

CAR-T cells

Chimeric antigen receptor (CAR) T cells are cells that are genetically engineered to recognize and target specific proteins. The ability of these cells to recognize cancer antigens and eliminate tumor cells have transformed cancer immunotherapy approaches. Here is the latest research on CAR-T cells.

Cancer -Omics

A variety of different high-throughput technologies can be used to identify the complete catalog of changes that characterize the molecular profile of cohorts of tumor samples. Discover the latest insights gained from cancer 'omics' in this feed.

Cancer Cell Invasion: Nanomedicine

Nanomedicine is a promising alternative for cancer detection and therapy that utilizes nanoparticles, such as liposomes. Nanoparticles can potentially target cancer cell invasion and metastasis. Discover the latest research on Cancer Cell Invasion: Nanomedicine here.

Cancer Disparities

Cancer disparities refers to differences in cancer outcomes (e.g., number of cancer cases, related health complications) across population groups.

Cancer Immunotherapy

Cancer immunotherapy is an important field of research that is looking at controlling cancer and tumor growth by activating the individuals own immune system. Recent studies have utilized chimeric antigen receptor t-cell therapy, immune checkpoint inhibitors and neoantigen vaccines. Discover the latest research on cancer immunotherapy here.

Cancer Incidence & Mortality

Cancer has emerged as a global concern due to its increase in incidence and mortality. Efforts are underway to evaluate and develop action plans to reduce the global burden of cancer. Currently, lung cancer, breast cancer and prostate cancer are the leading causes of cancer mortality. Here is the latest research on cancer incidence and mortality.

Cancer Metabolic Reprogramming

Cancer metabolic reprogramming is important for the rapid growth and proliferation of cancer cells. Cancer cells have the ability to change their metabolic demands depending on their environment, regulated by the activation of oncogenes or loss of tumor suppressor genes. Here is the latest research on cancer metabolic reprogramming.

© 2021 Meta ULC. All rights reserved